DiaMedica Therapeutics Inc. (DMAC)
NASDAQ · Healthcare
DiaMedica Therapeutics Inc. Income Statement 2018–2018
| Dec 2018 | |
|---|---|
| Revenues | |
| Revenue | 500,000 |
| Gross Profit | — |
| Profitability | |
| Operating Income | -6.8M |
| EBITDA | — |
| Net Income | -5.7M |
| Per Share Data | |
| EPS (diluted) | — |
| Shares Outstanding (dil.) | 12M |
DiaMedica Therapeutics Inc. Income Statement — FAQ
DiaMedica Therapeutics Inc. (DMAC) income statement over the last 1 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DMAC's income statement history?
The chart and table above show DiaMedica Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.